The role of galectin-3 in endocytosis of advanced glycation end products and modified low density lipoproteins

Biochem Biophys Res Commun. 2001 Feb 2;280(4):1183-8. doi: 10.1006/bbrc.2001.4256.

Abstract

Galectin-3, a member of beta-galactoside-binding lectin family, is suggested to be an AGE-receptor. To examine this possibility, we prepared CHO cells overexpressing human galectin-3 (galectin-3-CHO cells). Galectin-3-CHO cells showed a specific and saturable binding to (125)I-AGE-BSA with Kd of 3.1 microg/ml. (125)I-AGE-BSA was endocytosed by galectin-3-CHO cells and underwent lysosomal degradation. The endocytosis of (125)I-AGE-BSA was inhibited not only by unlabeled AGE-BSA but also by acetylated LDL and oxidized LDL, ligands for the scavenger receptor family. Furthermore, (125)I-oxidized LDL and (125)I-acetylated LDL were actively endocytosed by galectin-3-CHO cells and the incubation with acetyl-LDL led to intracellular accumulation of cholesteryl esters, indicating the role of galectin-3 in endocytosis of AGE-proteins and modified LDLs. Since galectin-3 was localized and up-regulated in foam cells at human atherosclerotic lesions, the present results suggest that galectin-3 plays an important role in formation of atherosclerotic lesions in vivo, by modulating endocytic uptake of AGE-proteins and modified LDLs.

MeSH terms

  • Animals
  • Antigens, Differentiation / genetics
  • Antigens, Differentiation / immunology
  • Antigens, Differentiation / physiology*
  • CHO Cells
  • Cattle
  • Cricetinae
  • Dose-Response Relationship, Drug
  • Endocytosis*
  • Galectin 3
  • Glycation End Products, Advanced / metabolism*
  • Humans
  • Kinetics
  • Ligands
  • Lipoproteins, LDL / metabolism*
  • Oxygen / metabolism
  • Serum Albumin / metabolism
  • Transfection

Substances

  • Antigens, Differentiation
  • Galectin 3
  • Glycation End Products, Advanced
  • Ligands
  • Lipoproteins, LDL
  • Serum Albumin
  • Oxygen